MBD2 and cancer: As JMJD6 has long been identified as a demethylase for histone H4 at arginine 3 (H4R3), and H4R3me2 is a key epigenetic event in cancer,16,26 the binding of symmetric H4R3me2 on A549 genome was also assessed.